Plus   Neg

Foundation Medicine Inc. (FMI) Has Broken Out To A New High After FDA Approval

Foundation Medicine Inc. (FMI) announced Thursday that it has received approval from the FDA for FoundationOne CDx, its diagnostic test for solid tumors.

Foundation Medicine gapped open sharply higher Friday morning and has continued to rise in early trade. Shares are now up 7.10 at $60.30. The stock has broken out of a 1-month trading range and has set a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT